Related Experiment Video
Updated: Aug 18, 2026

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
Cimetidine treatment of recurrent ulcer after proximal gastric vagotomy
Abstract:
Twenty-one patients with endoscopically confirmed recurrent ulceration after proximal gastric vagotomy entered an open trial of treatment with cimetidine, 1.0 g/day. Twenty patients completed 6 weeks' treatment, and repeat endoscopy showed ulcer healing in 18 of 20 patients. One patient's ulcer was found to be healed on X-ray examination, and the other patient had a healed ulcer after an additional 2 weeks' treatment. Eighteen of the patients with healed ulcer entered a maintenance trial of cimetidine, 400 mg at night. During the 1-year follow-up period the occurrence of symptoms led to re-endoscopy in 11 patients. Re-ulceration was confirmed in six patients (33%), and mean time to ulcer recurrence was 18.2 weeks. Ulcer recurrence was treated with an increased dose of cimetidine and antacids. All the ulcers then healed again, and the patients remained well on a maintenance dose of cimetidine, 800 mg/day. None of the patients had to be operated on during the trial. Two patients developed gynaecomastia during maintenance treatment with 400 mg cimetidine a day. No serious untoward signs or symptoms occurred that necessitated withdrawal from the trial. It seems as if recurrent ulcers after proximal gastric vagotomy respond to cimetidine treatment approximately as do peptic ulcers in unoperated patients.
More Related Videos
04:05Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
Published on: August 22, 2025
04:08Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease